http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1095940-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c275038cf36535d44a526cb28203c03d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate | 2000-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e505d7b6bc38fcf2ccb73e33c6988bab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19949fd3ed6326cc004add4cc8d0df1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61244674fbd634e1a8342feb6580b7b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa2f47eb03c91cc213b90cbd1e140158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddbe392a7dff95a847c466ded39e9a04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_544af01a08905e8ae54f126ac826a0d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6c3fcaa2d38c9ed7f3c768f218cafe3 |
| publicationDate | 2001-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1095940-A2 |
| titleOfInvention | Derivatives of 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphto[2,3-d][1,3]dioxol-6(5aH)-one, method for their preparation and pharmaceutical compositions containing them |
| abstract | un groupement de formule (i) : ndans laquelle X, Y et W sont tels que définis dans la description, ou un groupement de formule (ii) : - A - G (ii) ndans laquelle :n A représente une liaison simple ou une chaíne alkylène éventuellement substituée, G représente un groupement choisi parmi atome d'hydrogène, cycloalkyle,nhétérocycloalkyle, aryle, hétéroaryle, -OR 2 , -O-T 1 -NR 3 R 4 , -O-T 1 -NR 2 -T 1 -NR 3 R 4 , -NR 3 R 4 ,n-NR 2 -T 1 -NR 3 R 4 , -NR 2 -T 1 -OR 5 , -NR 2 -T 1 -CO 2 R 6 , -NR 2 -T 1 -C(O)R 6 , -C(O)-NR 3 R 4 ,n-C(O)-NR 2 -T 2 , -O-C(O)-T 2 , -O-C(S)-T 2 , -NR 2 -C(O)-T 2 , -NR 2 -C(S)-T 2 , -O-C(O)-O-T 2 ,n-O-C(O)-NR 2 -T 2 , -O-C(S)-O-T 2 , -O-C(S)-NR 2 -T 2 , -NR 2 -C(O)-O-T 2 , -NR 2 -C(O)-NR 6 -T 2 ,n-NR 2 -C(S)-O-T 2 , -NR 2 -C(S)-NR 6 -T 2 , et -NR 2 -SO 2 -T 3 , ndans lesquels R 2 , R 3 , R 4 , R 5 , R 6 , T 1 , T' 1 , T 2 et T 3 sont tels que définis dans landescription, R 1 représente un groupement choisi parmi hydrogène, alkyle, aryle, arylalkyle, hétéroaryle,nhétéroarylalkyle, alkylcarbonyle, arylcarbonyle, arylalkylcarbonyle, hétérocycloalkylcarbonyle,nalkylsulfonyle, arylsulfonyle, arylalkylsulfonyle, phosphonique,naryloxycarbonyle, alkoxycarbonyle, ou arylalkoxycarbonyle, nleurs isomères ainsi que leurs sels d'addition à un acide ou à une base pharmaceutiquementnacceptable.Compounds of formula (I): in which : R represents: a group of formula (i): in which X, Y and W are as defined in the description, or a group of formula (ii): - A - G (ii) in which : A represents a single bond or an optionally substituted alkylene chain, G represents a group chosen from hydrogen, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, -OR 2 , -OT 1 -NR 3 R 4 , -OT 1 -NR 2 -T 1 -NR 3 R 4 , -NR 3 R 4 , -NR 2 -T 1 -NR 3 R 4 , -NR 2 -T 1 -OR 5 , -NR 2 -T 1 -CO 2 R 6 , -NR 2 -T 1 -C (O) R 6 , -C (O) -NR 3 R 4 , -C (O) -NR 2 -T 2 , -OC (O) -T 2 , -OC (S) -T 2 , -NR 2 -C (O) -T 2 , -NR 2 -C (S) -T 2 , -OC (O) -OT 2 , -OC (O) -NR 2 -T 2 , -OC (S) -OT 2 , -OC (S ) -NR 2 -T 2 , -NR 2 -C (O) -OT 2 , -NR 2 -C (O) -NR 6 -T 2 , -NR 2 -C (S) -OT 2 , -NR 2 -C (S) -NR 6 -T 2 , and -NR 2 -SO 2 -T 3 , in which R 2 , R 3 , R 4 , R 5 , R 6 , T 1 , T ' 1 , T 2 and T 3 are as defined in the description, R 1 represents a group chosen from hydrogen, alkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, alkylcarbonyl, arylcarbonyl, arylalkylcarbonyl, heterocycloalkylcarbonyl, alkylsulfonyl, arylsulfonyl, arylalkylsulfonyl, phosphonic, aryloxycarbonylarbonoxycarbonyl their isomers and their addition salts with a pharmaceutically acceptable acid or base.n n n Medicines. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004073375-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004073375-A2 |
| priorityDate | 1999-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.